Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis

Immunity

Volumn 45, Issue 1, 2016, Pages 145-158

  Gieseck, Richard L ^a,b   Ramalingam, Thirumalai R ^a   Hart, Kevin M ^a   Vannella, Kevin M ^a   Cantu, David A ^a   Lu, Wei Yu ^c   Ferreira González, Sofía ^c   Forbes, Stuart J ^c   Vallier, Ludovic ^b,d   Wynn, Thomas A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CRE RECOMBINASE; EPITHELIAL CELL ADHESION MOLECULE; GENOMIC DNA; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRIACYLGLYCEROL; BILE ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL AGING; CELL FRACTIONATION; CELL PROLIFERATION; CELL SURVIVAL; CHOLANGIOCYTE; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; FATTY LIVER; INJURY SEVERITY; INTRAHEPATIC CHOLESTASIS; LIVER CELL; LIVER FIBROSIS; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION; TH2 CELL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; BILIARY CIRRHOSIS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; FIBROBLAST; FIBROSIS; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

ANIMALS; BILE ACIDS AND SALTS; CELL PROLIFERATION; CELLS, CULTURED; FATTY LIVER; FIBROBLASTS; FIBROSIS; HUMANS; INTERLEUKIN-13; LIVER; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84990859074     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.06.009     Document Type: Article

References (53)

1. Alison, M.R., Lovell, M.J., Liver cancer: the role of stem cells. Cell Prolif. 38 (2005), 407–421.
2. Beck, L.A., Thaçi, D., Hamilton, J.D., Graham, N.M., Bieber, T., Rocklin, R., Ming, J.E., Ren, H., Kao, R., Simpson, E., et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N. Engl. J. Med. 371 (2014), 130–139.
3. Borthwick, L.A., Barron, L., Hart, K.M., Vannella, K.M., Thompson, R.W., Oland, S., Cheever, A., Sciurba, J., Ramalingam, T.R., Fisher, A.J., Wynn, T.A., Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol. 9 (2016), 38–55.
4. Brightling, C.E., Chanez, P., Leigh, R., O'Byrne, P.M., Korn, S., She, D., May, R.D., Streicher, K., Ranade, K., Piper, E., Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir. Med. 3 (2015), 692–701.
5. Chandriani, S., DePianto, D.J., N'Diaye, E.N., Abbas, A.R., Jackman, J., Bevers, J. 3rd, Ramirez-Carrozzi, V., Pappu, R., Kauder, S.E., Toy, K., et al. Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts. J. Immunol. 193 (2014), 111–119.
6. Chen, F., Liu, Z., Wu, W., Rozo, C., Bowdridge, S., Millman, A., Van Rooijen, N., Urban, J.F. Jr., Wynn, T.A., Gause, W.C., An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 18 (2012), 260–266.
7. Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W., Wynn, T.A., An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104 (1999), 777–785.
8. Chiaramonte, M.G., Mentink-Kane, M., Jacobson, B.A., Cheever, A.W., Whitters, M.J., Goad, M.E.P., Wong, A., Collins, M., Donaldson, D.D., Grusby, M.J., Wynn, T.A., Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197 (2003), 687–701.
9. Choy, D.F., Hart, K.M., Borthwick, L.A., Shikotra, A., Nagarkar, D.R., Siddiqui, S., Jia, G., Ohri, C.M., Doran, E., Vannella, K.M., et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci. Transl. Med., 7, 2015, 301ra129.
10. Clouston, A.D., Powell, E.E., Walsh, M.J., Richardson, M.M., Demetris, A.J., Jonsson, J.R., Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005), 809–818.
11. Danese, S., Rudziński, J., Brandt, W., Dupas, J.L., Peyrin-Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukas, M., Knutsson, M., et al. Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study. Gut 64 (2015), 243–249.
12. Farber, E., Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res. 16 (1956), 142–148.
13. Font-Burgada, J., Shalapour, S., Ramaswamy, S., Hsueh, B., Rossell, D., Umemura, A., Taniguchi, K., Nakagawa, H., Valasek, M.A., Ye, L., et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 162 (2015), 766–779.
14. Foo, S.S., Turner, C.J., Adams, S., Compagni, A., Aubyn, D., Kogata, N., Lindblom, P., Shani, M., Zicha, D., Adams, R.H., Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124 (2006), 161–173.
15. Goh, Y.P.S., Henderson, N.C., Heredia, J.E., Red Eagle, A., Odegaard, J.I., Lehwald, N., Nguyen, K.D., Sheppard, D., Mukundan, L., Locksley, R.M., Chawla, A., Eosinophils secrete IL-4 to facilitate liver regeneration. Proc. Natl. Acad. Sci. USA 110 (2013), 9914–9919.
16. Hamilton, J.D., Suárez-Fariñas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., Ming, J.E., Radin, A.R., Krueger, J.G., Graham, N., et al. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J. Allergy Clin. Immunol. 134 (2014), 1293–1300.
17. Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., Mankertz, J., Gitter, A.H., Bürgel, N., Fromm, M., et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129 (2005), 550–564.
18. Henderson, N.C., Arnold, T.D., Katamura, Y., Giacomini, M.M., Rodriguez, J.D., McCarty, J.H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P.G., et al. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat. Med. 19 (2013), 1617–1624.
19. Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.M., Ellis, E., van Wenum, M., Fuchs, S.A., de Ligt, J., et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160 (2015), 299–312.
20. Jörs, S., Jeliazkova, P., Ringelhan, M., Thalhammer, J., Dürl, S., Ferrer, J., Sander, M., Heikenwalder, M., Schmid, R.M., Siveke, J.T., Geisler, F., Lineage fate of ductular reactions in liver injury and carcinogenesis. J. Clin. Invest. 125 (2015), 2445–2457.
21. Karimian, N., Op den Dries, S., Porte, R.J., The origin of biliary strictures after liver transplantation: is it the amount of epithelial injury or insufficient regeneration that counts?. J. Hepatol. 58 (2013), 1065–1067.
22. Kaviratne, M., Hesse, M., Leusink, M., Cheever, A.W., Davies, S.J., McKerrow, J.H., Wakefield, L.M., Letterio, J.J., Wynn, T.A., IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173 (2004), 4020–4029.
23. Landi, A., Weismuller, T.J., Lankisch, T.O., Santer, D.M., Tyrrell, D.L.J., Manns, M.P., Houghton, M., Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis. J. Interferon Cytokine Res. 34 (2014), 204–214.
24. Li, J., Bessho, K., Shivakumar, P., Mourya, R., Mohanty, S.K., Dos Santos, J.L., Miura, I.K., Porta, G., Bezerra, J.A., Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J. Clin. Invest. 121 (2011), 4244–4256.
25. Li, J., Razumilava, N., Gores, G.J., Walters, S., Mizuochi, T., Mourya, R., Bessho, K., Wang, Y.H., Glaser, S.S., Shivakumar, P., Bezerra, J.A., Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J. Clin. Invest. 124 (2014), 3241–3251.
26. Lin, J., Lu, F., Zheng, W., Xu, S., Tai, D., Yu, H., Huang, Z., Assessment of liver steatosis and fibrosis in rats using integrated coherent anti-Stokes Raman scattering and multiphoton imaging technique. J. Biomed. Opt., 16, 2011, 116024.
27. Liu, F., Song, Y., Liu, D., Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999), 1258–1266.
28. Liu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P.R., Dooley, S., Weng, H.L., IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling. J. Immunol. 187 (2011), 2814–2823.
29. Lowes, K.N., Brennan, B.A., Yeoh, G.C., Olynyk, J.K., Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol. 154 (1999), 537–541.
30. Lu, W.Y., Bird, T.G., Boulter, L., Tsuchiya, A., Cole, A.M., Hay, T., Guest, R.V., Wojtacha, D., Man, T.Y., Mackinnon, A., et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat. Cell Biol. 17 (2015), 971–983.
31. Means, A.L., Xu, Y., Zhao, A., Ray, K.C., Gu, G., A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. Genesis 46 (2008), 318–323.
32. Metwally, S.S., Mosaad, Y.M., Abdel-Samee, E.R., El-Gayyar, M.A., Abdel-Aziz, A.M., El-Chennawi, F.A., IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity. Egypt. J. Immunol. 11 (2004), 171–177.
33. Murray, L.A., Zhang, H., Oak, S.R., Coelho, A.L., Herath, A., Flaherty, K.R., Lee, J., Bell, M., Knight, D.A., Martinez, F.J., et al. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am. J. Respir. Cell Mol. Biol. 50 (2014), 985–994.
34. Park, Y.N., Kojiro, M., Di Tommaso, L., Dhillon, A.P., Kondo, F., Nakano, M., Sakamoto, M., Theise, N.D., Roncalli, M., Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 109 (2007), 915–923.
35. Pearce, E.J., MacDonald, A.S., The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2 (2002), 499–511.
36. Ramalingam, T.R., Pesce, J.T., Sheikh, F., Cheever, A.W., Mentink-Kane, M.M., Wilson, M.S., Stevens, S., Valenzuela, D.M., Murphy, A.J., Yancopoulos, G.D., et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat. Immunol. 9 (2008), 25–33.
37. Reiman, R.M., Thompson, R.W., Feng, C.G., Hari, D., Knight, R., Cheever, A.W., Rosenberg, H.F., Wynn, T.A., Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect. Immun. 74 (2006), 1471–1479.
38. Ricardo-Gonzalez, R.R., Red Eagle, A., Odegaard, J.I., Jouihan, H., Morel, C.R., Heredia, J.E., Mukundan, L., Wu, D., Locksley, R.M., Chawla, A., IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc. Natl. Acad. Sci. USA 107 (2010), 22617–22622.
39. Richardson, M.M., Jonsson, J.R., Powell, E.E., Brunt, E.M., Neuschwander-Tetri, B.A., Bhathal, P.S., Dixon, J.B., Weltman, M.D., Tilg, H., Moschen, A.R., et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 133 (2007), 80–90.
40. Roskams, T., Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25 (2006), 3818–3822.
41. Roskams, T.A., Theise, N.D., Balabaud, C., Bhagat, G., Bhathal, P.S., Bioulac-Sage, P., Brunt, E.M., Crawford, J.M., Crosby, H.A., Desmet, V., et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39 (2004), 1739–1745.
42. Sancho-Bru, P., Altamirano, J., Rodrigo-Torres, D., Coll, M., Millán, C., José Lozano, J., Miquel, R., Arroyo, V., Caballería, J., Ginès, P., Bataller, R., Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 55 (2012), 1931–1941.
43. Schaap, F.G., van der Gaag, N.A., Gouma, D.J., Jansen, P.L., High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 49 (2009), 1228–1235.
44. Scheerens, H., Arron, J.R., Zheng, Y., Putnam, W.S., Erickson, R.W., Choy, D.F., Harris, J.M., Lee, J., Jarjour, N.N., Matthews, J.G., The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin. Exp. Allergy 44 (2014), 38–46.
45. Shimamura, T., Fujisawa, T., Husain, S.R., Kioi, M., Nakajima, A., Puri, R.K., Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J. Immunol. 181 (2008), 4656–4665.
46. Sorrentino, P., Terracciano, L., D'Angelo, S., Ferbo, U., Bracigliano, A., Tarantino, L., Perrella, A., Perrella, O., De Chiara, G., Panico, L., et al. Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. J. Gastroenterol. 45 (2010), 1053–1062.
47. Sparks, E.E., Huppert, K.A., Brown, M.A., Washington, M.K., Huppert, S.S., Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice. Hepatology 51 (2010), 1391–1400.
48. Stanya, K.J., Jacobi, D., Liu, S., Bhargava, P., Dai, L., Gangl, M.R., Inouye, K., Barlow, J.L., Ji, Y., Mizgerd, J.P., et al. Direct control of hepatic glucose production by interleukin-13 in mice. J. Clin. Invest. 123 (2013), 261–271.
49. Sugimoto, R., Enjoji, M., Nakamuta, M., Ohta, S., Kohjima, M., Fukushima, M., Kuniyoshi, M., Arimura, E., Morizono, S., Kotoh, K., Nawata, H., Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 25 (2005), 420–428.
50. Wang, B., Zhao, L., Fish, M., Logan, C.Y., Nusse, R., Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524 (2015), 180–185.
51. Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 368 (2013), 2455–2466.
52. Wynn, T.A., Type 2 cytokines: mechanisms and therapeutic strategies. Nat. Rev. Immunol. 15 (2015), 271–282.
53. Yanger, K., Knigin, D., Zong, Y., Maggs, L., Gu, G., Akiyama, H., Pikarsky, E., Stanger, B.Z., Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 15 (2014), 340–349.